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Background: One of the main challenges in biomedicine is improvement of detection sensi-
tivity to achieve tumor marker recognition at a very low concentration when the disease is not 
significantly advanced. A pivotal role in cancer defense is played by the p53 tumor suppressor, 
therefore its detection with high sensitivity may contribute considerably to early diagnosis of 
cancer. In this work, we present a new analytical method based on surface-enhanced Raman 
spectroscopy which could significantly increase the sensitivity of traditional bioaffinity 
  techniques. p53 molecules were anchored to gold nanoparticles by means of the bifunctional 
linker 4-aminothiophenol (4-ATP). The characteristic vibrational bands of the p53-4-ATP 
nanoparticle system were then used to identify the p53 molecules when they were captured by 
a recognition substrate comprising a monolayer of azurin in molecules possessing significant 
affinity for this tumor suppressor. The Raman signal enhancement achieved by 4-ATP-mediated 
crosslinking of p53 to 50 nm gold nanoparticles enabled detect of this protein at a concentration 
down to 5 × 10−13 M.
Keywords: surface-enhanced Raman spectroscopy, p53, ultrasensitive detection, atomic force 
microscopy
Introduction
Tumor markers play an important role in cancer diagnosis and many efforts are cur-
rently devoted to development of ultrasensitive and rapid analytical approaches to 
identify them.1,2
The human p53 tumor suppressor is considered an indicator of special interest 
because its tissue and/or serum level has been associated with tumor invasiveness and 
prognosis in patients with various malignant diseases.3–7 For this reason, several p53 
detection procedures have been developed.8–16 Undoubtedly, among these procedures, 
the most common ones are the traditional fluorescence-labeled immunological methods 
such as the enzyme-linked immunosorbent assay.8–11 However, these methods require 
multiple steps, long incubation periods, and provide only a semiquantitative analysis.12 
In addition to the more traditional methods, novel label-free detection techniques have 
paved the way for the realization of protein chip-based immunoassays with enhanced 
sensitivity and specificity.13–16
On the other hand, nanoparticle applications have received much attention in clini-
cal diagnosis in the last few years.15,17,18 Gold nanocolloids have been widely used to 
design immunoassay tests for tumor markers, based on their peculiar properties of 
a high surface-to-volume ratio, the possibility of suitable biomolecular conjugation, 
their rewarding chemical stability, and the collective electronic behavior at their International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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  surface. In particular, their optical and electromagnetic signal 
enhancement capability, combined with their ability to form 
hybrid assemblies with biomolecules,2,15 provide the basis for 
ultrasensitive and molecular specific detection.
Within this context, exploitation of surface-enhanced 
Raman scattering (SERS)19–22 offers great promise for sim-
plified, sensitive detection of biomolecular interactions and 
several advantages in early diagnostic over the previously 
mentioned assay methodologies.23–27 SERS is based on the 
huge enhancement of the Raman cross-section of molecules 
when they are placed in the proximity of a nanostructured 
metal surface,28 due to the contribution of an electromagnetic 
and chemical or charge transfer effect.19,29,30 Depending on 
both the chemical nature of the adsorbed molecules and the 
metal surface features, SERS may reach a 1010-fold increase 
of conventional Raman detection sensitivity.21,22,31
In previous work we have demonstrated the remarkable 
potential of this approach in the detection of single molecules 
and in nanobiodiagnostics.23–26 Proceeding from these studies, 
we now report a novel SERS-based detection method arising 
from the synergic combination of Raman signal enhancement 
and the bioaffinity assay, by which it has been possible to 
lower the current threshold sensitivity considerably in the 
detection of p53. In particular, we have exploited the spe-
cific interaction of p53 with azurin, a bacterial blue-copper 
protein. Indeed, cellular32,33 and molecular studies34,35 have 
demonstrated that azurin is an exogenous vector able to enter 
cancer cells preferentially and form a specific and stable 
complex with human p53, increasing its tumor suppressor 
activity. It is believed that their interaction involves a portion 
of the hydrophobic patch surrounding the copper-containing 
active site of azurin, and the DNA binding domain of p53,32,35 
within which the majority of the p53 tumor-derived mutation 
resides. In our laboratory, the binding and kinetic features of 
the azurin-p53 complex have been recently investigated by 
single-molecule atomic force spectroscopy and by surface 
plasmon resonance.34,36 These studies have demonstrated 
that this complex is significantly stable and that the azurin-
p53 interaction is affected neither by the immobilization 
strategies used nor by the binding of the Mdm2 protein to p53, 
with the former playing a key physiological role in lowering 
the intracellular stability of p53.36
In this work we used the 4-aminothiophenol (4-ATP) 
linker, which has on one side a thiol group able to bind to a 
gold nanoparticle, and on the other side a diazonium moiety 
capable of reacting with the electron-rich aromatic lateral 
chains of p53. p53 conjugated to a gold nanoparticle was 
transferred onto a capture substrate composed of an azurin 
monolayer, and the strong intense SERS bands, characteristic 
of the p53-4-ATP nanoparticle system, were followed to 
identify the p53 molecules recognized by the azurin partner 
molecules. This approach was demonstrated to be able to 
reveal p53 initially present in a solution at 5 × 10−13 M. The 
proposed methodology couples remarkable sensitivity with 
high selectivity, even in the presence of other proteins present 
in the human serum environment.
Materials and methods
Materials
Gold colloidal nanoparticles with a mean diameter of 
48.9 ± 3.9 nm (water solution of 4.5 × 1010 particles/mL; gold 
chloride concentration 0.01%), were purchased from Ted 
Pella (Reading, CA). Solid 4-ATP (assay 97%, absorbivity 
∈ = 9600 M−1⋅cm−1), human serum albumin, human serum, 
and azurin were purchased from Sigma-Aldrich (St Louis, 
MO). The proteins were dissolved in 50 mM phosphate buffer 
(pH 7.2). A characteristic spectral absorption ratio of 0.48 at 
630 nm and 280 nm was found for azurin solution, indicating 
a good degree of purity of the protein.37–39
Human glutathione S-transferase (GST)-p53 1.23 mM in 
50 mM Tris-acetate, pH 7.5, 1 mM EDTA, 20% glycerol) was 
purchased from Millegen (Labège, France). Cleavage of the 
GST portion was achieved by digestion with the thrombin 
CleaveClean kit (Sigma) according to the manufacturer’s 
instructions.
The purity of the proteins was assessed using gel electro-
phoresis experiments. The thrombin-purified proteins were 
separated by sodium dodecyl sulfate polyacrylamide gel elec-
trophoresis (SDS-PAGE) and analyzed by densitometry. All 
thrombin-cleaved preparations were of $95% homogeneity. 
The wild-type conformation of purified p53 was verified by 
an immunoprecipitation technique, using two conformation-
specific antibodies and circular dichroism measurements. 
The methods used to assess the quality, correct folding, and 
purity of the proteins have been published elsewhere.40 The 
water used for the experiments was purified using a Milli-Q 
Reagent water system (Millipore, Bedford, MA).
Methods
The procedure used to functionalize the gold nanoparticles 
is briefly described in Figure 1A. In the first step, a gold 
nanoparticle mother solution was mixed with 4-ATP 
(0.5 mg/mL in absolute ethanol) in a volume ratio of 1:1. 
The solution obtained was incubated at 20°C for three hours. 
The formation of a covalent bond between 4-ATP and the 
gold nanoparticles was followed by Raman spectroscopy24 International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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and ultraviolet-visible spectrophotometry (see Results 
  section). According to the literature,24 we have estimated 
that about 104 4-ATP molecules can fully cover a single 
gold nanoparticle.
To remove the excess of unbound 4-ATP and promote 
the ethanol to Milli-Q water solvent exchange, the solution 
was dialyzed by a membrane (purchased from Spectra/Por®), 
having a molecular weight cutoff of 100 kDa. Dialysis was 
stopped when no more 4-ATP was detected by ultraviolet-
visible spectroscopy in the fluid beyond the membrane. In the 
second step, diazo coupling chemistry24,41,42 was employed 
for the covalent capture of p53 (or azurin in the alternative 
configuration) onto gold nanoparticles exposing the aromatic 
amino compound 4-ATP.
To this end, 200 µL of acidified nitrosating agent NaNO2 
(0.1 M, pH 3) was added to 200 µL of the dialyzed 4-ATP 
nanoparticle solution very slowly and under constant stir-
ring for 15 minutes at about 2°C. Only rare bubbles of 
nitrogen were observed, confirming the stability of the 
diazotized 4-ATP nanoparticle system. The reaction was 
monitored by adding phenol to the mixture, since this 
confers a characteristic red color to the solution when the 
product appears in the reaction. Excesses of nitrous acid 
and hydrochloric acid were removed by dialysis against 
Milli-Q ice water at 2°C, and the pH of the resulting solu-
tion was stabilized at 7.2 by phosphate buffer, avoiding the 
hazard of deamination and unfolding of proteins during the 
coupling reaction.
The diazonium compound obtained was slowly added to 
200 µL of p53 (from 10−9 to 10−13 M, pH 7.2), or alternatively 
of azurin (1 × 10−5 M, pH 7.2) and kept under gentle stirring 
at 2°C for two hours. The final solution was further dialyzed 
to remove unbound proteins. The success of the diazo cou-
pling reaction was assessed by Raman and ultraviolet-visible 
spectroscopy (see Results section) and the efficiency of the 
coupling reaction was estimated to be about 0.5. Under the 
described conditions, proteins were expected to be involved 
in the diazo coupling with 4-ATP-nanoparticle mainly 
by means of their exposed histidyl and tyrosyl groups24,42 
(see Figure 1A).
Glass substrates were cleaned by sonication in acetone 
for two minutes and subjected to Piranha etch (H2O2:H2SO4, 
1:3 v/v) which strongly increases the number of silanol 
groups on the surface. Successively, they were treated with 
3-  amino-propyl triethoxy-silane dissolved in 2-propanol 
(8% solution) for four hours to form a self-assembled 
monolayer.43 The modified plates were thoroughly rinsed 
with 2-propanol, baked at 110°C for 10 minutes, and then 
reacted with 1% glutaraldehyde solution for 30 minutes at 
room temperature.43,44 After thoroughly rinsing with Milli-Q 
water, the aldehyde-modified surfaces were incubated with 
azurin (1 × 10−5 M) or with different molar ratios of p53/
human serum albumin (at a minimum concentration of 
5 pmol) to form a self-assembled protein monolayer through 
their solvent-exposed amino groups36 (see Figure 1B). Addi-
tional control experiments were carried out by incubating the 
functionalized substrate with human serum solution.
Tapping-mode atomic force microscopy (TM-AFM) 
images in buffer solution (pH 7.2), using a cantilever 
force constant, k, of 0.5 N/m, a scan rate of 1 Hz, and a 
1 µm × 1 µm scan size, were recorded by a Park XE-100 mul-
timode scanning probe microscope during the different steps 
of the sample preparation.
The protein-covered substrates were incubated for 
three hours at room temperature with the corresponding 
protein partner previously conjugated to 4-ATP nanopar-
ticles in phosphate buffer solution (pH 7.2), allowing the 
azurin-p53 interaction. Then the substrates were washed 
with phosphate buffer to remove the unbound p53-4-ATP 
nanoparticles. For each protein concentration, three samples 
were prepared to repeat independent experiments.
C=N
C=N
Si
OO
C=N
C=N
Si
O O O
Glass slide
O O O O
C=N
C=N
Si
C=N
C=N
Si
NH2
NH2
N=N
p53
N
NH
SH
SA u
SA u
4-ATP
4-ATP-Np
p53-(4-ATP-Np)
p53
Az
Step 1
Step 2
A
BA zA zA zA z
Au
Np
Au
Np
Figure 1 chemical reactions (left side) and schematic sketches (right side) describing 
the functionalization of (A) gold nanoparticles with p53 and (B) glass slides with 
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Raman and SERS spectra were recorded in air at 20°C by 
a Labram confocal setup (Jobin-Yvon, Edison, NJ) equipped 
with a Peltier-cooled CCD detector and a single-grating 
spectrograph (1800 grooves/mm), allowing a resolution of 
5 cm−1 and a 16-bit dynamic range. The microscope objec-
tive was 100× with a numerical aperture of 0.9 producing a 
laser spot size of about 1 µm in diameter. The source was 
a He-Ne laser (Melles Griot) providing 632.8 nm radiation 
with power emerging from the objective of 6.5 ± 0.5 mW. 
SERS spectra were acquired by scanning different sample 
areas per time unit, at the same confocal section. This 
allowed us to increase the irradiated number of SERS “hot 
spots” and, at the same time, to reduce the bleaching effects 
on the irradiated sample. The typical Raman acquisition 
parameter was an integration time of 20 seconds with five 
scan repetitions. Optical absorbance was recorded at room 
temperature using a double-beam Jasco V-550 ultraviolet-
visible spectrophotometer with 1 cm path length cuvettes 
and a 0.5 nm bandwidth.
Results
The approach developed for SERS detection of p53 at 
very low concentrations is shown in Figure 1. The 4-ATP 
molecules are linked to gold nanoparticles by means of a 
covalent S-Au bond, and the resulting 4-ATP nanoparticle 
system is successively conjugated to p53 molecules via a 
diazo coupling reaction to form the p53-4-ATP   nanoparticle 
system (Figure 1A). Glass slides are instead treated in 
sequence with silane and glutaraldehyde and then reacted 
with azurin to form the capture substrate (Figure 1B). The 
p53-4-ATP nanoparticle system is then incubated onto the 
azurin platform to allow p53 recognition, capture, and suc-
cessive Raman interrogation.
Each step of the p53-4-ATP nanoparticle system assem-
bly was investigated by Raman spectroscopy and the result-
ing spectra are shown in Figure 2. The vibrational bands 
found in the selected wave number region where the main 
spectral changes occur are listed in Table 1, together with 
the literature-based assignments.45–48
We can note striking differences between the spectra of 
the 4-ATP linker before (Figure 2A) and after (Figure 2B) 
conjugation with the gold nanoparticles. Indeed, the forma-
tion of an S-Au covalent bond, indicative of conjugation of 
4-ATP with gold nanoparticles, is evident from the disappear-
ance of the band centered at 2550 cm−1, inherent to the stretch-
ing vibration of S-H (see the insets of Figure 2A and B).24,48 
Moreover, most of the peaks in the 1000–1700 cm−1 region 
of 4-ATP show a strong intensity increase upon binding to 
the nanoparticles, together with some changes in the rela-
tive intensity, with an appreciable frequency red-shift also 
observed.
After the diazotization reaction, which involves the con-
jugation of p53 through its exposed histidine and/or tyrosine 
residues, the SERS spectrum of the whole p53-4-ATP 
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nanoparticle system displays an additional band centered at 
about 1328 cm−1 (Figure 2C). The new band is assigned to the 
stretching vibration modes of the diazo bond (−N=N−) which 
keeps the protein tightly linked to the 4-ATP nanoparticle 
system.46,49,50 The intensity of this band increases with the p53 
concentration used for the diazotization reaction (not shown), 
indicating that each 4-ATP nanoparticle system is able to con-
jugate a progressively increasing number of p53 molecules as 
the concentration of the latter is raised. Indeed, we estimated 
that up to about 250 p53 molecules can be effectively bound 
onto a single 50 nm 4-ATP   nanoparticle.24   Accordingly, the 
band at 1328 cm−1 constitutes the spectroscopic fingerprint 
of the covalent conjugation of p53 to a 4-ATP   nanoparticle, 
and its presence then reflects the capture of p53 by the azurin-
containing recognition element. Other Raman bands at around 
1390 and 1435 cm−1, characteristic of the 4-ATP nanoparticle 
system, were also followed to check the conjugation of 4-ATP 
to the nanoparticles.
The stepwise molecular assembly of p53-4-ATP nano-
particles was also investigated using ultraviolet-visible 
spectroscopy, by monitoring the resonant absorption bands 
due to the collective oscillations of surface electrons of 
the gold nanoparticles, called localized surface plasmons. 
Figure 3 shows that the bare nanoparticles are characterized 
by an absorption band centered at about 530 nm (full line). 
Upon binding of 4-ATP to the nanoparticles, a shift of the 
plasmonic resonance band from 530 nm up to a maximum of 
541 nm (Figure 3, light dots) is observed. Since the red-shift 
is proportional to the number of molecules adsorbed onto the 
gold nanoparticles,19,20,22,51 we can reasonably assume that, at 
the maximum shift, the nanoparticles surface is fully covered 
by 4-ATP molecules. After conjugation of the p53 molecules, 
a further wavelength shift from 541 nm up to a maximum 
of 555 nm is registered (Figure 3, dashed line). At this 
maximum shift, it is reasonable to assume that each 4-ATP 
nanoparticle is fully covered by p53 molecules. Moreover, the 
Table  1  selected  raman  and  sers  bands  of  4-ATP,  4-ATP 
nanoparticle and p53-4-ATP nanoparticles with their vibrational 
assignments
Vibrational 
assignment
4-ATP 
Raman 
(cm-1)
4-ATP-NP 
SERS 
(cm-1)
p53-(4-ATP NP) 
SERS 
(cm-1)
sc str + Nh2 rock 1089 sa 1079 s 1076 s
ch bend 1176 wa 1141 ma 1140 w
cN bend 1211 vwa 1190 w 1182 w
NN str 1328 s
cc str + ch rock + 
Nh2 rock
1388 m 1390 m
cc str + Nh2 rock 1433 m 1436 m
cc str + ch bend 1492 w 1470;1483 w 1470;1483 w
cc str + Nh2 bend 1593 s 1580 s 1572 s
sh str 2555 w
Abbreviations: a, intensity; s, strong; m, medium; w, weak; vw, very weak; str, 
stretch; sers, surface-enhanced raman scattering; NP, nanoparticles
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Figure 3 Optical absorption of water solutions of: 50 nm gold nanoparticles (full line), 4-ATP nanoparticles (light dots), and p53-4-ATP nanoparticles (dashed line). The 
localized plasmon absorption band of the latter is fitted by two components centred at 555 nm and 630 nm (heavy dots).International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2038
Domenici et al
0
100
200
300
400
0
100
200
300
400
0
100
200
300
400
0
1020 1080 1140 1200 1260 1320 1380
Wavenumber [cm−1]
I
n
t
e
n
s
i
t
y
 
[
a
.
u
.
]
1440 1500 1560 1620 1680
100
200
300
400
A
B
C
D
(p53 5 × 10−11 M)
Az-modified glass substrate
(p53 5 × 10−12 M)
(p53 5 × 10−13 M)
p53
Au Np
Az
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with the p53-4-ATP nanoparticle system, at different p53 concentrations, 5 × 10–11 M (B), 5 × 10–12 M (C), and 5 × 10–13 M (D). spectra were collected by an objective 
100× immersed in phosphate buffer.
  absorption peak also displays a marked shoulder on the red 
side (Figure 3, dashed profile) with a Gaussian deconvolu-
tion, indicating a contribution from a further plasmonic band 
centered at 630 nm (Figure 3, heavy dots).47
To detect p53 we flowed the p53-4-ATP nanoparticle 
solution onto a capture platform made up of an immobilized 
azurin monolayer. After brief incubation, the system was 
rinsed several times to remove the unbound p53-4-ATP 
nanoparticle molecules and was then interrogated by SERS 
spectroscopy. Figure 4 shows the SERS spectra of such an 
azurin substrate, before (Figure 4A) and after (Figure 4B–D) 
the addition of progressively decreasing concentrations of p53 
bound to 4-ATP nanoparticles. While the characteristic Raman 
fingerprint is absent in Figure 4A, it can be clearly observed in 
Figure 4B–D, confirming the presence of p53 molecules which 
were recognized and captured by azurin. The Raman signal 
to noise ratio is progressively reduced upon decreasing the 
p53 concentration. Below 5 × 10−13 M (Figure 4D), this ratio 
becomes too low (signal to noise ratio ,3) and therefore we 
can assume that such a concentration is the lowest detection 
limit for p53 by our method. A control experiment in which 
we dropped 4-ATP nanoparticle molecules (1 pmol of gold 
nanoparticles) without p53 onto the azurin-coated platform, 
resulted in a spectrum similar to that shown in Figure 4A, thus 
revealing no recognition events. These SERS experiments 
were repeated on three independent samples for each p53 
concentration, and obtained good reproducibility. The Raman 
fingerprint intensity showed a variability of about 5% within 
samples at the same concentration. In addition, this intensity 
scaled down in a good correlation with the concentration 
decrease of p53.
Interestingly, we were able to detect p53-azurin biorec-
ognition events even when the SERS bands became hard to 
distinguish over the noise (at subpicomolar concentrations 
of p53). To this end, we used a TM-AFM topographical 
investigation able to detect the formation of biorecognition 
complexes (p53-azurin) at the level of a single molecule.23 
Figure 5 shows representative TM-AFM images of the azurin-
coated substrate before (Figure 5A) and after incubation with 
p53-4-ATP nanoparticles (Figure 5B). In Figure 5A, the verti-
cal profile reveals isotropic molecule packing with a height 
of about 3.1 ± 0.5 nm and roughness (Rq) of 1.7 ± 0.5 nm, 
which are consistent with those of an azurin monolayer.52 
Figure 5B shows instead large and rather regular spots 
(height 55 ± 8 nm) appearing on the substrate, consistent 
with the nanoparticles (diameter about 50 nm) bound to p53 
(diameter about 5.5 nm).34 Images similar to that shown in 
Figure 5A were also recorded for the substrate after incubation International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
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(and   successive rinsing) with 4-ATP-nanoparticles lacking 
p53. These results indicate that the single atomic force micro-
scopic spots correspond to single capture events between azu-
rin and p53. We also occasionally observed dimers, indicating 
the presence of a few aggregates in our sample.
Although this atomic force microscopic approach is quite 
promising for very ultrasensitive detection, it requires further 
investigation to gain some ground from a quantitative point of 
view and reproducibility. However, it did allow us to estimate 
the amount of complexes formed on the substrate. Indeed, 
a   statistical analysis of recorded images revealed that the com-
plexes formed corresponded to about 20% of the total amount 
of p53-4-ATP nanoparticle molecules incubated with azurin. 
This indicates that only 20% of the functionalized nanopar-
ticles give rise to successful interactions with the substrate.
To check if the method was able to reveal the tumor 
marker p53 among other proteins selectively, we first ana-
lyzed if the capture of p53 from azurin was affected by the 
presence of a molar excess of human serum albumin. The 
latter is the most abundant protein in human blood serum. 
We used an alternative configuration in which azurin was 
conjugated with 4-ATP nanoparticles by diazotization, and 
then used the SERS marker to screen the various samples. 
We incubated different samples containing p53 and human 
serum albumin at various concentrations on glass slides 
bearing aldehyde moieties on their surface, to allow 
immobilization of both human serum albumin and p53.36 
Successively, we flowed the azurin-4-ATP nanoparticle 
systems onto these substrates and performed SERS measure-
ments after extensive rinsing to remove what had not been 
captured by the protein-coated substrates. Figure 6 shows 
representative SERS spectra of samples with human serum 
albumin/p53 at a molar ratio of 0, 10, 100, and 1000, and 
samples containing only human serum albumin, with all of 
them treated with our azurin-modified nanoparticles. It is 
worthy of note that the intensity of the SERS bands char-
acteristic of the azurin-4-ATP nanoparticle system undergo 
a progressive decrease with increasing of the human serum 
albumin/p53 molar ratio (Figure 6A–D). These bands 
are absent on the substrate containing only human serum 
albumin (Figure 6E). Therefore, it can be inferred that the 
fingerprint SERS signal arose only from the azurin-4-ATP 
nanoparticle molecules which formed a complex with p53 
immobilized onto the substrate.
Notably, the Raman marker derived from conjugation of 
azurin to the 4-ATP nanoparticle gives a more intense SERS 
signal than that corresponding to the previous configuration, 
due to the higher number of azurin molecules surrounding 
each nanoparticle. Indeed, by assuming that azurin and 
p53 can be represented as spheres with a diameter of about 
3 nm and 6 nm, respectively, we can estimate that about 
980 molecules of azurin and 250 molecules of p53 can be, 
at maximum, closely packed around each nanoparticle, the 
diameter of which is about 50 nm.
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A competitive experiment was also performed using human 
serum which is known to contain other molecules besides 
  albumin. For this purpose, glass slides bearing aldehyde 
moieties were incubated with human serum. Subsequently, 
the azurin-4-ATP nanoparticle solution was flowed on these 
substrates to check for any interaction between azurin and the 
molecules contained in the serum. After rinsing, no appreciable 
SERS signal over the noise was detected, and the resulting 
spectrum was indeed similar to that shown in Figure 6E. This 
indicates that the azurin-modified nanoparticles do not interact 
with human serum molecules, so no interference with the p53-
azurin complex formation can be reasonably inferred.
Discussion
Our Raman-SERS results show that the p53-4-ATP nanoparti-
cle system exhibits remarkable enhancement of the fingerprint 
Raman signal, with vibrational features well distinguishable 
and stable in time. Generally, the huge enhancement of the 
Raman cross-section when the molecules are bound to a metal 
surface (SERS effect) is attributed to two main SERS mecha-
nisms, ie, an electromagnetic mechanism associated with a 
large local field caused by surface plasmon resonance, and a 
charge transfer from the metal to the adsorbed molecules.19,29,30 
For 4-ATP molecules bound to gold nanoparticles, the 
enhancement of bands at about 1141 cm−1 and 1435 cm−1 seen 
in Figure 2B can be ascribed to the charge transfer   mechanism, 
while the other bands reported in Table 1 for 4-ATP nano-
particles are thought to be selectively enhanced mainly via 
electromagnetic mechanisms.45–48 From the signal to noise 
intensity ratio of the C-S stretching mode (around 1089 cm−1 
and 1078 cm−1 for the solid 4-ATP and the 4-ATP nanoparticle 
system, respectively), enhancement due to a SERS effect of 
about seven orders of magnitude was estimated.
Such a huge enhancement allowed us to demonstrate p53 
at extremely low concentrations (down to about 5 × 10−13 M) 
which should be compared with those obtained by the other 
methods reported in the literature. Recent research reports 
novel bioaffinity-based methods, employing consensus DNA 
sequences and monoclonal antibodies adsorbed onto surface 
plasmon resonance sensor discs, gold electrodes, and metal 
nanostructures, which are able to improve the tumor marker 
detection limits of the enzyme-linked immunosorbent assay 
test. These new techniques can demonstrate p53 at picomolar 
concentrations,53,54 indicating that our detection value is com-
parable with or even better than the best results obtained by 
these biosensors.53 Nevertheless, our method has the advantage 
of low concentrations which are easy to detect and a relatively 
short assay time. In addition, it does not require multiple steps, 
as does the classical sandwich enzyme immunoassay. Notably, 
our SERS-based   detection approach is amenable to further 
improvements of the enhancement factor by optimizing the 
dimensions of the gold nanoparticles, the distance between the 
Raman marker and the nanoparticle surface, and perhaps even 
the arrangement of azurin molecules on the substrate.
The presence of very few larger spots in the TM-AFM 
images, reasonably attributed to the formation dimers, finds 
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a correspondence with the observation of plasmonic modes 
centered at around 630 nm in the ultraviolet-visible spectra, 
which can likely be attributed to some interparticle coupling 
effects.47 Accordingly, we can hypothesize that, during the 
diazo coupling reaction, some p53 molecules may form mul-
tiple bonds with different azotated 4-ATP nanoparticles, thus 
promoting interparticle modulation of the common localized 
plasmonic band. Such an effect could be responsible for some 
colloid polydispersivity.
A further lowering of the detection level could also be 
achieved by coupling SERS with the single molecule capabil-
ity of atomic force microscopy imaging which allows moni-
toring of formation of an individual complex. Indeed, the 
observation by TM-AFM of large spots on the azurin-coated 
substrate after incubation with the p53-4-ATP nanoparticle 
solution showed the effective deposition of nanoparticles 
on the substrate, with concomitant formation of specific 
complexes between azurin and p53.
The ability of our method to detect p53 specifically among 
the other molecules present in human serum provides an indi-
cation of the selectivity of this method. Such a property, cou-
pled with high reproducibility, accuracy and speed, represents 
a starting point for further implementation in real   biosensors. 
In this respect, we suggest that monitoring of p53 in serum 
could be extremely helpful as an indicator of prognosis 
and response to chemotherapy and radiotherapy in various 
malignant diseases,3–7 and even to relate their insurgence to 
genotoxic environmental carcinogenic exposure.11,55–57
Conclusion
The proposed azurin-based SERS approach for detection 
of the p53 tumor suppressor combines high sensitivity 
and   selectivity. It is able to detect p53 at a concentration 
of 5 × 10−13 M, with the further ability to reveal the target 
biomolecule selectively in the presence of human serum 
albumin, and even in the serum environment in which other 
biomolecules are present. Accordingly, it can constitute a 
basis to design novel protocols for early clinical screening 
of human and environmental pathologies. This strategy 
can be easily extended to the detection of multiple specific 
analytes, thus providing a multiplex assay for ultrasensitive 
and targeted screening. Additionally, a combination of this 
SERS-based detection method with atomic force microscopic 
topography offers the opportunity to improve further the 
detection sensitivity towards the single molecule regime.
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